What is the catalog number for Brequinar-d3?

The catalog number for Brequinar-d3 is HY-108325S.

What sizes are available for Brequinar-d3?

Brequinar-d3 is available in the following size(s): 1 Each.

Is Brequinar-d3 in stock?

Brequinar-d3 is currently made to order / not held in immediate stock. Contact us for lead time.

Who manufactures Brequinar-d3?

Brequinar-d3 is manufactured by QuantiMol.

What is the estimated delivery time for Brequinar-d3?

Estimated delivery time for Brequinar-d3 is approximately 15 business day(s), depending on your location.

Where can I find the safety data sheet (SDS/MSDS) for Brequinar-d3?

The safety data sheet for Brequinar-d3 is available here: http://file.medchemexpress.com/batch_PDF/HY-108325S/.

Brequinar-d3

Brequinar-d3 (DUP785-d3) is deuterium labeled Brequinar. Brequinar (DUP785) is a potent inhibitor of dihydroorotate dehydrogenase (DHODH) with an IC50 of 5.2 nM for human DHODH. Brequinar has potent activities against a broad spectrum of viruses. Brequinar also has an anti-SARS2 activity[1].

Product Specifications

Product Name Alternative

DUP785-d3; NSC 368390-d3

UNSPSC

12352005

Target

Dihydroorotate Dehydrogenase; DNA/RNA Synthesis; Isotope-Labeled Compounds; SARS-CoV; Virus Protease

Type

Isotope-Labeled Compounds

Related Pathways

Anti-infection; Cell Cycle/DNA Damage; Metabolic Enzyme/Protease; Others

Field of Research

Cancer; Infection; Inflammation/Immunology

Smiles

O=C(C1=C(C([2H])([2H])[2H])C(C2=CC=C(C3=CC=CC=C3F)C=C2)=NC4=CC=C(F)C=C14)O

Molecular Formula

C23H12D3F2NO2

Molecular Weight

378.39

References & Citations

[1]Russak EM, et al. Impact of Deuterium Substitution on the Pharmacokinetics of Pharmaceuticals. Ann Pharmacother. 2019 Feb;53 (2) :211-216.|[2]Schnellrath LC, et al. Potent antiviral activity of brequinar against the emerging Cantagalo virus in cell culture. Int J Antimicrob Agents. 2011 Nov;38 (5) :435-41.|[3]Qing M, et al. Characterization of dengue virus resistance to brequinar in cell culture. Antimicrob Agents Chemother. 2010 Sep;54 (9) :3686-95.|[4]Xu X, et al. In vitro and in vivo mechanisms of action of the antiproliferative and immunosuppressive agent, brequinar sodium. J Immunol. 1998 Jan 15;160 (2) :846-53.|[5]Zeping Zuo, et al. Bifunctional Naphtho[2,3-d][1,2,3]triazole-4,9-dione Compounds Exhibit Antitumor Effects In Vitro and In Vivo by Inhibiting Dihydroorotate Dehydrogenase and Inducing Reactive Oxygen Species Production. J Med Chem. 2020 Jun 4.|[6]David C Schultz, et al. Pyrimidine inhibitors synergize with nucleoside analogues to block SARS-CoV-2. Nature. 2022 Feb 7.